SLC28A1
Sodium/nucleoside cotransporter 1
Also known as: CNT1, S28A1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00337
- Gene
- SLC28A1
- Ensembl
- ENSG00000156222
- Chromosome
- 15
- Canonical length
- 649 aa
- Protein class
- Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters
- Subcellular location
- Nuclear speckles,Plasma membrane,Cytosol
OverviewNCBI Gene
Enables azole transmembrane transporter activity; pyrimidine- and adenosine-specific:sodium symporter activity; and uridine transmembrane transporter activity. Involved in azole transmembrane transport and nucleoside transport. Located in apical plasma membrane; cytosol; and nuclear speck. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
649 residues, UniProt reviewed canonical sequence.
>O00337|SLC28A1
1 MENDPSRRRE SISLTPVAKG LENMGADFLE SLEEGQLPRS DLSPAEIRSS WSEAAPKPFS
61 RWRNLQPALR ARSFCREHMQ LFRWIGTGLL CTGLSAFLLV ACLLDFQRAL ALFVLTCVVL
121 TFLGHRLLKR LLGPKLRRFL KPQGHPRLLL WFKRGLALAA FLGLVLWLSL DTSQRPEQLV
181 SFAGICVFVA LLFACSKHHC AVSWRAVSWG LGLQFVLGLL VIRTEPGFIA FEWLGEQIRI
241 FLSYTKAGSS FVFGEALVKD VFAFQVLPII VFFSCVISVL YHVGLMQWVI LKIAWLMQVT
301 MGTTATETLS VAGNIFVSQT EAPLLIRPYL ADMTLSEVHV VMTGGYATIA GSLLGAYISF
361 GIDATSLIAA SVMAAPCALA LSKLVYPEVE ESKFRREEGV KLTYGDAQNL IEAASTGAAI
421 SVKVVANIAA NLIAFLAVLD FINAALSWLG DMVDIQGLSF QLICSYILRP VAFLMGVAWE
481 DCPVVAELLG IKLFLNEFVA YQDLSKYKQR RLAGAEEWVG DRKQWISVRA EVLTTFALCG
541 FANFSSIGIM LGGLTSMVPQ RKSDFSQIVL RALFTGACVS LVNACMAGIL YMPRGAEVDC
601 MSLLNTTLSS SSFEIYQCCR EAFQSVNPEF SPEALDNCCR FYNHTICAQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC28A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 13
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 107 nTPM
Expression across tissuesHPA
Tissue
- liver: 107 nTPM
- kidney: 47 nTPM
- small intestine: 46 nTPM
- duodenum: 36 nTPM
- tongue: 3.1 nTPM
- skeletal muscle: 1.4 nTPM
Single-cell type
- proximal tubule cells: 406 nCPM
- enterocytes: 248 nCPM
- hepatocytes: 150 nCPM
- hofbauer cells: 124 nCPM
- epididymal efferent duct absorptive cells: 34 nCPM
- epididymal basal cells: 33 nCPM
Immune cell
- neutrophil: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- medulla oblongata: 1.9 nTPM
- white matter: 1.4 nTPM
- spinal cord: 1.1 nTPM
- pons: 1 nTPM
- midbrain: 0.8 nTPM
- hypothalamus: 0.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC28A1.
Disease | AllUniProt
Conditions SLC28A1 is implicated in, by any mechanism.
- Uridine-cytidineuria (URCTU) MIM:618477
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.25
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.74
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- azole transmembrane transport
- cytidine transport
- nucleoside transmembrane transport
- purine nucleobase transmembrane transport
- pyrimidine nucleobase transport
- pyrimidine-containing compound transmembrane transport
- uridine transmembrane transport
- nucleoside import across plasma membrane
Molecular functions
- azole transmembrane transporter activity
- cytidine transmembrane transporter activity
- nucleoside:sodium symporter activity
- purine nucleobase transmembrane transporter activity
- pyrimidine- and adenosine-specific:sodium symporter activity
- uridine transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Concentrative nucleoside transporter N-terminal domain
- Concentrative nucleoside transporter
- Nucleoside transporter/FeoB GTPase, Gate domain
- Concentrative nucleoside transporter C-terminal domain
- Concentrative nucleoside transporter, metazoan/bacterial
- Na+ dependent nucleoside transporter N-terminus
- Na+ dependent nucleoside transporter C-terminus
- Nucleoside recognition
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC28A1 as an antibody target. Whether an autoantibody or antibody against SLC28A1 could matter depends on whether native SLC28A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC28A1 is annotated at the cell surface, where native SLC28A1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC28A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...